X4 Pharmaceuticals, Inc.
XFOR
$3.70
-$0.18-4.52%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 94.11% | -27.60% | -14.80% | -24.39% | -20.02% |
| Total Receivables | -13.89% | 58.86% | -31.35% | 59.37% | 25.64% |
| Inventory | 28.71% | 2.62% | 9.66% | 15.21% | 194.22% |
| Prepaid Expenses | -5.15% | 10.55% | -19.77% | 24.82% | -10.05% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 82.07% | -23.78% | -14.69% | -21.54% | -18.50% |
|
|
|||||
| Total Current Assets | 82.07% | -23.78% | -14.69% | -21.54% | -18.50% |
| Net Property, Plant & Equipment | -31.28% | -29.93% | -14.50% | -8.51% | -6.85% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -1.94% | -1.92% | -1.87% | -1.85% | -1.80% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -16.26% | -22.00% | 44.86% | -11.98% | 32.08% |
| Total Assets | 55.52% | -19.11% | -11.22% | -17.80% | -15.41% |
|
|
|||||
| Total Accounts Payable | -34.45% | -30.64% | 28.93% | 0.51% | 7.40% |
| Total Accrued Expenses | 25.82% | 3.60% | -45.18% | 18.22% | -1.44% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -12.28% | 4.99% | 4.16% | 2.37% | 4.27% |
| Total Finance Division Other Current Liabilities | 7.96% | -11.81% | -- | -- | -- |
| Total Other Current Liabilities | 7.96% | -11.81% | -- | -- | -- |
| Total Current Liabilities | 2.66% | -11.54% | -21.27% | 12.37% | 1.23% |
|
|
|||||
| Total Current Liabilities | 2.66% | -11.54% | -21.27% | 12.37% | 1.23% |
| Long-Term Debt | 0.29% | 0.28% | 0.27% | 0.27% | 0.26% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -88.34% | -26.51% | -21.35% | -19.75% | -13.28% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 38.18% | -63.01% | -69.51% | 18.54% | 20.61% |
| Total Liabilities | 0.73% | -5.48% | -13.86% | 4.85% | 2.05% |
|
|
|||||
| Common Stock & APIC | 16.05% | 1.26% | 0.10% | 0.44% | 0.34% |
| Retained Earnings | -5.51% | -5.00% | 0.05% | -8.37% | -8.36% |
| Treasury Stock & Other | 14.49% | -7.81% | -4.92% | -7.02% | 28.30% |
| Total Common Equity | 1,451.73% | -82.69% | 3.59% | -62.85% | -36.88% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1,451.73% | -82.69% | 3.59% | -62.85% | -36.88% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1,451.73% | -82.69% | 3.59% | -62.85% | -36.88% |
|
|
|||||